Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NEPHNEPH
Showing 8 of 16 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NEPHROS INC

Yes. Citadel Advisors holds 29,044 shares of NEPH (Nephros), worth $103,687, as of its Q2 2026 13F filing. It increased the position by 8,156 shares (+39.1%) from Q1 2026. Citadel Advisors has held NEPH since Q2 2024, across 9 quarterly 13F filings.

Current Value

$103,687

Current Shares

29,044

Total Value Change

+$74,213

Total Shares Change

+11,808

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
29,044
+39.0%
$103,6870.0%$3.57
20
2026-Q1
Increased
20,888
+0.9%
$62,2460.0%$2.98
14
2025-Q4
Increased
20,710
+25.2%
$101,0650.0%$4.88
18
2025-Q3
Increased
16,545
+39.1%
$78,2580.0%$4.73
19
2025-Q2
Decreased
11,890
-1.1%
$48,6300.0%$4.09
0
2025-Q1
Decreased
12,024
-15.8%
$20,6810.0%$1.72
0
2024-Q4
Decreased
14,289
-17.1%
$20,8620.0%$1.47
0
2024-Q3
Increased
17,236
+45.5%
$29,4740.0%$1.71
18

Other major holders of NEPH: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used